Abingdon Health (LON:ABDX) Sets New 1-Year Low – Time to Sell?

Abingdon Health Plc (LON:ABDXGet Free Report) shares hit a new 52-week low on Friday . The company traded as low as GBX 6.50 ($0.08) and last traded at GBX 6.99 ($0.09), with a volume of 118945 shares. The stock had previously closed at GBX 7.25 ($0.09).

Abingdon Health Stock Down 3.6 %

The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company’s fifty day moving average price is GBX 7.70 and its 200-day moving average price is GBX 8.24. The stock has a market capitalization of £13.53 million, a PE ratio of -17.00 and a beta of 0.13.

About Abingdon Health

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.

Further Reading

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.